Coronaviruses
The World's First International Journal Dedicated to Coronaviruses
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Volume 2, 12 Issues, 2021
ISSN: 2666-7975 (Online)
ISSN: 2666-7967 (Print)
This journal supports open access
Aims & Scope
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.
Coronaviruses
,Volume 2
-Number 10
Review Article Open Access
Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
, 2(10): e170821190015Subhash Chandra*, Sarla Saklani and Hassan Y. Aboul-Enein*
DOI: 10.2174/2666796701666210108115614
Hydroxychloroquine Sulfate (Plaquenil): A Possible Candidate for Pandemic SARS-CoV-2 or (COVID-19) ?
Review Article Open Access
COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
, 2(10): e170821191026Manal A. Hamed*
DOI: 10.2174/2666796702666210202124650
COVID-19 Invades Several Important Organs other than the Lungs: Organs Crosstalk
Review Article Open Access
Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
, 2(10): e170821191322Mohammad Ramazii, Delnia Ebadi , Maryam Farzaneh*, Farhoodeh Ghaedrahmati and Seyed Esmaeil Khoshnam
DOI: 10.2174/2666796702666210211121614
Mesenchymal Stem Cells: A Potent Cell Source for COVID-19
Review Article Open Access
Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
, 2(10): e170821190795M. Beyau Konyak, Richa Naredi, Ekta Rana and Ramendra Pati Pandey*
DOI: 10.2174/2666796702666210127111351
Diagnosis and Possible Use of Traditional Medicinal Plant to combat COVID-19
Review Article Open Access
Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
, 2(10): e170821191027Asim Azhar*, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, Jae-Jung Dong, Mohammad Amjad Kamal and Mohammad Owais
DOI: 10.2174/2666796702666210202125638
Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
Review Article Open Access
Adjuvant Therapies of COVID-19 - A Literature Review
, 2(10): e170821190562Naina Mohamed Pakkir Maideen*
DOI: 10.2174/2666796702666210121144902
Adjuvant Therapies of COVID-19 - A Literature Review
Review Article (Mini-Review) Open Access
Review on Diagnostic Methods for SARS-CoV-2
, 2(10): e170821189088Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh and Amita Verma*
DOI: 10.2174/2666796701999201211213517
Review on Diagnostic Methods for SARS-CoV-2
Review Article (Mini-Review) Open Access
Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
, 2(10): e170821190247Rashmy Nair, Ravindra Singh Rao, Placheril Joseph John and Poonam Khandelwal*
DOI: 10.2174/2666796702999210112203139
Immunity Modulators, Repurposed Drugs and Candidate Vaccines for COVID-19: A Review
Coronaviruses, Volume 2 (2021) - Number 12
This issue is in progress but contains articles that are final and fully citable.
Coronaviruses, Volume 2 (2021) - Number 11
This issue is in progress but contains articles that are final and fully citable.
Articles Ahead of Print
HOCl as a Promising Candidate for Effective Containment of Covid 19 From Biological and Non-Biological Surfaces
Sandeep Kumar Shukla*, Ajay Kumar Sharma, Aman Kalonia and Priyanka Shaw
DOI: 10.2174/2666796702666210906120232
View Abstract
Identification of Flavonoids as a Potent Inhibitors Against MERS-CoV 3C-like Protease
Fatemeh Abdi and Shahrzad Javanshir*
DOI: 10.2174/2666796702666210709115659
View Abstract
Withdrawal Notice: Detection of Viruses and development of new treatments: Insights into Antibody-Antigen Interactions and Multifunctional Lab-On-Particle for SARS CoV-2
A. Guillermo Bracamonte*, Martin Amé, Esraa Samy Abu Serea and Ahmed Esmail Shalan
DOI: 10.2174/2666796702666210329142505
View Abstract
Withdrawal Notice: Current Drug Trends for the Treatment of the SARS- CoV-2
Márcio Robert Mattos da Silva*, Melanie Tavares, Ralph Santos-Oliveira and Eduardo RicciJúnior
DOI: 10.2174/2666796701999201222114336
View Abstract
Withdrawal Notice: Global Comprehensive Outlook of Hantavirus Contagion on Humans: A Review
Sumel Ashique, Navjot K Sandhu*, Supratim Das, Sk. Niyamul Haque and Kartick Koley
DOI: 10.2174/2666796701999200922091340
View Abstract
A Critical Appraisal of the Risk of Bias in Systematic Reviews and Metaanalyses Pertaining to COVID-19
Amit Dang*, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang and Vallish B.N.
DOI: 10.2174/2666796701666201230105144
View Abstract
Screening for Potential Traditional Herbal Inhibitors Against 3Chymotrypsin- Like Main Protease (3CLpro) from Four Different Coronaviruses: An in-silico Approach
Prachi Singh, P. Ardra, V.R. Hariprasad, U.V. Babu , Mohamed Rafiq* and Raghavendra Pralhada Rao*
DOI: 10.2174/2666796702666210216142508
View Abstract
Abstracts Ahead of Print
Liver and Covid-19 - a review and clinical approach
David L Fisher and Stephen Malnick*
DOI: 10.2174/2666796702666211005142343
View Abstract
Cytokine Storm and Immunomodulation in COVID-19: a Review
Amir Mohammad Arsh, Suhana Mishra, Vishwas Tripathi* and Amaresh Mishra
DOI: 10.2174/2666796702666210913100327
View Abstract
Alternative Management Of Cushing's Syndrome During Covid-19 Pandemic
Serghei Covantev*, Stanislav I. Volkov* and Kristina I. Samsonova
DOI: 10.2174/2666796702666210913095645
View Abstract
Cordycepin and its nucleoside analogs for the treatment of systemic COVID-19 infection
Chellapandi P* and Saranya S
DOI: 10.2174/2666796702666210910111551
View Abstract
Total Stromal Fraction (TSF) - Fortified Adipose tissue-derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise
Madhan Jeyaraman, Sathish Muthu, Rashmi Jain, Ajay SS, Neha Garg, Prabhu Mishra, Kumari Swati, Anand Parkash, Niraj Kumar Jha*, Shreesh Ojha, Shubhadeep Roychoudhury, Dhruv Kumar, Janne Ruokolainen , Mohammad Amjad Kamal *, Kavindra Kumar Kesari* and Saurabh Kumar Jha*
DOI: 10.2174/2666796702666210908151708
View Abstract
History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
Amaresh Mishra, Nisha Nair, Vishwas Tripathi*, Yamini Pathak and Jaseela Majeed
DOI: 10.2174/2666796702666210805101958
View Abstract
COVID-19 Vaccines: Fabrication Techniques and Current Status
Ayushi Mahajan, Lakhvir Kaur*, Gurjeet Singh, RK Dhawan, Lovepreet Singh and Anureet Kaur
DOI: 10.2174/2666796702666210728150704
View Abstract
Anti-COVID-19 Sulfonamides: A DFT, docking and ADMET study
Ashique Al Hoque, Chayan Guha, Nayim Sepay, Sankar P Dey and Umesh C Halder*
DOI: 10.2174/2666796702666210719103409
View Abstract
Published Contents
Editor's Choice
Lipid Lowering Natural Products Targeting hPCSK9 May Prevent the Severity of COVID-19 Infection
, 2021; 2(11): 10 - 23Ajoy Basak*, Jaishree Vaijanathappa and Sarmistha Basak
DOI: 10.2174/2666796702666210329141042
Review on Diagnostic Methods for SARS-CoV-2
, 2021; 2(10): 8 - 14Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh and Amita Verma*
DOI: 10.2174/2666796701999201211213517
Immunological Response of the Respiratory Tract in the SARS-CoV-2 Infection
, 2021; 2(9): 8 - 17Sanjiv Singh*, Punita Aggarwal and Velayutham Ravichandiran
DOI: 10.2174/2666796702666210216143545
In-silico Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARSCoV- 2
, 2021; 2(8): 15 - 27Ravi S Patel, Akash G Vanzara, Nimisha R Patel, Ajit M Vasava, Sachin M Patil and Kishore S Rajput*
DOI: 10.2174/2666796701999201223163604
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
, 2021; 2(6): 4 - 16Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo
DOI: 10.2174/2666796701999201218141035
The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review
, 2021; 2(5): 1 - 10Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, Md Sarfraz, Nawshad Muhammad and Syed A.A. Rizvi*
DOI: 10.2174/2666796701999201123101730
Emergence of a New Zoonotic COVID-19 that Creates a Pandemic: Update on Current Pharmacotherapeutics and Future Prospective of Plasma Therapy
, 2021; 2(4): 422 - 430Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar and Abul Kalam Najmi*
DOI: 10.2174/2666796701999201014160857
Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies
, 2021; 2(3): 353 - 358Mohammad Khalid Parvez* and Kartika Padhan
DOI: 10.2174/2666796701999201116125249
Symptoms, Transmission, Prevention and Treatment of Pandemic Corona Virus: A Review
, 2021; 2(2): 151 - 158Tinsae Kebede, Dharmendra Kumar* and Pramod Kumar Sharma
DOI: 10.2174/2666796701999200713191436
Vitamin D3 Deficiency and COVID-19
, 2021; 2(1): 2 - 3Olen R. Brown* and Martin R. Hullender
DOI: 10.2174/2666796701999200914112352
Open Access Articles
Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
, 2021; 2(12): 6 - 12Debjyoti Talukdar, Diane Ignacio and Madan Mohan Gupta*
Functionalized Photocatalytic Nanocoatings for Inactivating COVID-19 Virus Residing on Surfaces of Public and Healthcare Facilities
, 2021; 2(12): 5 - 13Manjunatha Channegowda *
The Synergic Role of Environmental Contaminants in the Immunological Effects of Viral Diseases, Such as COVID-19
, 2021; 2(12): 4 - 5Winfred Espejo*, José E Celis and Paulina Bahamode
Economic Fluctuations: The Aftermath of COVID 19 Pandemic
, 2021; 2(12): 3 - 10Saishiv Adithya and Koyeli Girigoswami*
Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2
, 2021; 2(12): 2 - 13Vikas Pandey, Indu Lata Kanwar, Tanweer Haider, Vishal Gour, Monika Vishwakarma, Avijit Kumar Bakshi, Ravishankar Yadav and Vandana Soni*
New Perspectives for SARS-CoV-2 Rapid Detection
, 2021; 2(12): 1 - 5Latifa Khattabi*, Mustapha Mounir Bouhenna and Feriel Sellam
Epidemiology, Evolution, Transmission, and Therapeutics of COVID-19 Outbreak: An Update on the Status
, 2021; 2(11): 9 - 17Karan Singh*, Amit Kumar Mittal* and Akash Gujral
Prevention and Management of SARS-CoV-2 Infection Among the Health Care Workers
, 2021; 2(11): 8 - 12Juhi Sharma and Divakar Sharma*
Nanotechnology Advancements in the Diagnosis and Prevention of COVID-19: Past and Future
, 2021; 2(11): 7 - 18Leander Corrie*, Raghunandan Gundaram and Latha Kukatil
Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic
, 2021; 2(11): 6 - 15Ashutosh Chauhan, Ankit Kumar, Sandeep Goyal, Sunil Kumar Joshi and Deepak Kumar Semwal*
SARS-CoV-2: Molecular Biology and Therapeutic Targets
, 2021; 2(11): 5 - 19Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar and Yuba Raj Pokharel*
Controlling Coronavirus Infection: ‘Plan B’ Based on Non-vaccine / Drug Interventions
, 2021; 2(11): 4 - 6Ram Kumar Dhaked*
Clinical Evidence and Therapeutic Treatments at the Time of the Coronaviruses Responsible for SARS: A Perspective and Points of view with a Focus on Vascular Endothelium
, 2021; 2(11): 3 - 8Gerardo Tricarico, Barbara Zavan and Valter Travagli*
Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19
, 2021; 2(11): 13 - 21Gabriella Patricia Adisurja and Arli Aditya Parikesit*
High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies
, 2021; 2(11): 12 - 21Khalid Parvez*, Arun A. Bhagwath, Rekha P.D, Sharif Hamed R. Almutiri, Ziyad Al Zeyadi and Suman V. Budihal
Most Cited Articles
Most Accessed Articles
Is COVID-19 a Systemic Disease?
, 2021; 2(5): 4-8.Sherif Mohamed*, Khaled Saad, Ghada Elgohary, Azza AbdElHaffez and Nashwa Abd El-Aziz
DOI: 10.2174/2666796701999201216101914
The Emergence of Novel Coronavirus Disease, Global Treatment Update and its Containment Strategies in Overpopulated Countries: A Review
, 2021; 2(5): 1-10.Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, Md Sarfraz, Nawshad Muhammad and Syed A.A. Rizvi*
DOI: 10.2174/2666796701999201123101730
Comprehensive Review on Epidemiology, Diagnosis and Auspicious Management of COVID 19
, 2021; 2(6): 6-18.Pratibha Auti*, Sagar Kothawade, Anagha Soundankar and Vinayak Kumbhar
DOI: 10.2174/2666796701999201021150744
The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov- 2 Infection and COVID-19
, 2021; 2(6): 4-16.Carolina Restini*, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim and Courtney Merlo
DOI: 10.2174/2666796701999201218141035
The Role of Nanoparticles as Nanocarriers for the Controlled Release of some Potential Existing Antiviral Drugs for SARS-CoV-2 Management: A Review
, 2021; 2(6): 7-18.Onome Ejeromedoghene*, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo and Richard O. Akinyeye*
DOI: 10.2174/2666796701999201209142419
Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options
, 2021; 2(4): 481-491.Veer Singh and Vishal Mishra*
DOI: 10.2174/2666796701999201005211854
COVID-19 Pandemic: Care for Indian Cancer Patients
, 2021; 2(4): 403-404.Sandeep Kumar*
DOI: 10.2174/2666796701999201026205030
Structure, Transmission, Diagnostic Symptoms, Host and Entry Mechanism of COVID-19: A Review
, 2021; 2(5): 3-11.Prashant Swapnil, Mukesh Meena*, Tansukh Barupal, Yashwant Sompura and Deepa Hada
DOI: 10.2174/2666796701999201116213826
Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19
, 2021; 2(7): 10-27.Jafrin Jobayer Sonju, Md. Rafi Anwar*, Md. Abul Kalam Azad, Umme Habiba Sultana, Kumar Kulldeep Niloy and Sajan Das
DOI: 10.2174/2666796702666210127111918
Natural Products as Anti-COVID-19 Agents: An In Silico Study
, 2021; 2(5): 10-17.Chandan Sarkar, Sarmin Jamaddar, Milon Mondal, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam* and Mohammad S. Mubarak*
DOI: 10.2174/2666796701999201116124851
Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review
, 2021; 2(9): 12-17.Ashok Kumar, Waseem Ahmad Ansari, Tanveer Ahamad, Mohammad Saquib and Mohammad Faheem Khan*
DOI: 10.2174/2666796701666210105114804
Coronavirus: History, Genome Structure and Pathogenesis
, 2021; 2(3): 325-338.B. Poonam and Prabhjot Kaur Gill*
DOI: 10.2174/2666796701999200918160354
Stroke and COVID-19 Pandemic: The Dilemma
, 2021; 2(8): 10-13.Sherif Mohamed*, Seham Abd El-Mohsen, Osama Abo El-Hassan, Azza AbdelHaffez and Nashwa Abd El-Aziz
DOI: 10.2174/2666796701666210106112342
A Study About the Impact of Weather, Life Expectancy and Tourism on the Transmission of COVID-19
, 2021; 2(6): 3-8.Pardeep Bishnoi, Prabhat Kumar*, Abhijeet Singh, Mukesh Kumar Sahu and Vikrant Bansal
DOI: 10.2174/2666796701999201014155715
The Current Outbreak of COVID-19 with Reference to India
, 2021; 2(4): 448-459.Harshita Gupta*
DOI: 10.2174/2666796701999201026203911
Editor-in-Chief
Jean-Marc Sabatier
Department of Biochemistry
Institute of NeuroPhysiopathology
Marseille, Cedex
(France)
Biography
Department of Biochemistry
Institute of NeuroPhysiopathology
Marseille, Cedex
Biography
Biography of Jean-Marc Sabatier
Jean-Marc SABATIER is a Director of research at the French CNRS, with PhD and HDR degrees in Biochemistry and Microbiology. He headed several academic research teams (CNRS, INSERM and University), as well as a combined academic-industry research laboratory devoted to the engineering of therapeutic peptides (ERT62, Marseilles, France). He was also a Director of Research for several French private companies as well as a Canadian public company. He acts as a Consultant for top pharmaceutical and cosmetic companies. Dr. Sabatier works in the field of animal toxins. He so far contributed to several books in toxinology and virology, and more than 160 scientific articles, 180 communications, and 53 patents in both biology and chemistry.
Honorary Senior Advisors
Ferid Murad
(USA)
Atta-ur-Rahman, FRS
(UK)
About the Journal
For Authors
For Librarians & Readers
Webmaster Contact: info@benthamscience.net